![]()
|
|
||||||||
J. Biol. Chem., Vol. 267, Issue 28, 19938-19943, Oct, 1992
MA O'Reilly, AG Geiser, SJ Kim, LA Bruggeman, AX Luu, AB Roberts and MB Sporn
Transforming growth factor TGF-beta 2 is encoded by multiple mRNA
transcripts of 5.8, 5.1, 4.0, 3.8, and 2.8 kilobase pairs (kb) that are
expressed in various human and monkey cells. Northern blot analysis using
genomic fragments of DNA was used to demonstrate that some of this size
heterogeneity is due to differences in the length of the 5'- untranslated
region. Probes that were colinear with the first 600 nucleotides of the
5'-untranslated region detected only the 5.8-, 4.0-, and 3.8-kb
transcripts. In order to identify DNA elements that regulate the
transcription of these mRNA transcripts, deletion constructs of 5'-
flanking DNA were ligated to the coding region for chloramphenicol
acetyltransferase (CAT) and analyzed for promoter activity in several cell
lines. Sequences responsible for putative enhancer and silencer regions
were identified between -778 and -40 relative to the transcription
initiation site. Addition of a cyclic AMP-responsive element/activating
transcription factor-like element at -74 resulted in a 5-10-fold increase
in CAT activity over that expressed with a construct that contained only
the TATA box. This increase in CAT activity was suppressed by the addition
of DNA sequences between -257 and -187, whereas sequences between -778 and
-257 stimulated CAT activity. Point mutations within the ATF binding site
at -74 resulted in a marked decrease in CAT expression. Cotransfection with
ATF-1 or ATF-2 expression plasmids resulted in both dose-dependent
stimulatory and inhibitory activities that were cell type-dependent. These
studies identify multiple transcription initiation sites for TGF-beta 2 and
demonstrate that transcription from one of these promoters is dependent
upon an ATF binding site located 5' of the TATA box.
Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter
Laboratory of Chemoprevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. Xia, M. T. Longaker, and G. P. Yang P38 MAP kinase mediates transforming growth factor-beta2 transcription in human keloid fibroblasts Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R501 - R508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Buck, K. Pfizenmaier, and C. Knabbe Antiestrogens Induce Growth Inhibition by Sequential Activation of p38 Mitogen-Activated Protein Kinase and Transforming Growth Factor-{beta} Pathways in Human Breast Cancer Cells Mol. Endocrinol., July 1, 2004; 18(7): 1643 - 1657. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, H. O. Akman, E. L. P. Smith, J. Zhao, J. E. Murphy-Ullrich, and O. A. Batuman Cellular response to hypoxia involves signaling via Smad proteins Blood, March 15, 2003; 101(6): 2253 - 2260. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Masuoka and T. M. Townes Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice Blood, February 1, 2002; 99(3): 736 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. Akman, H. Zhang, M. A. Q. Siddiqui, W. Solomon, E. L. P. Smith, and O. A. Batuman Response to hypoxia involves transforming growth factor-beta 2 and Smad proteins in human endothelial cells Blood, December 1, 2001; 98(12): 3324 - 3331. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Konrad, M. Albrecht, H. Renneberg, and G. Aumuller Transforming Growth Factor-{beta}2 Mediates Mesenchymal-Epithelial Interactions of Testicular Somatic Cells Endocrinology, October 1, 2000; 141(10): 3679 - 3686. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Rancourt, R. J. Staversky, P. C. Keng, and M. A. O'reilly Hyperoxia inhibits proliferation of Mv1Lu epithelial cells independent of TGF-beta signaling Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1172 - L1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Kingsley-Kallesen, D. Kelly, and A. Rizzino Transcriptional Regulation of the Transforming Growth Factor-beta 2 Promoter by cAMP-responsive Element-binding Protein (CREB) and Activating Transcription Factor-1 (ATF-1) Is Modulated by Protein Kinases and the Coactivators p300 and CREB-binding Protein J. Biol. Chem., November 26, 1999; 274(48): 34020 - 34028. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. HAN, M. ISONO, B. B. HOFFMAN, and F. N. ZIYADEH High Glucose Stimulates Proliferation and Collagen Type I Synthesis in Renal Cortical Fibroblasts: Mediation by Autocrine Activation ofTGF-{beta} J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1891 - 1899. [Abstract] [Full Text] |
||||
![]() |
B. Scholtz, M. Kingsley-Kallesen, and A. Rizzino Transcription of the Transforming Growth Factor-beta 2 Gene Is Dependent on an E-box Located between an Essential cAMP Response Element/Activating Transcription Factor Motif and the TATA Box of the Gene J. Biol. Chem., December 13, 1996; 271(50): 32375 - 32380. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morooka, J. V. Bonventre, C. M. Pombo, J. M. Kyriakis, and T. Force Ischemia and Reperfusion Enhance ATF-2 and c-Jun Binding to cAMP Response Elements and to an AP-1 Binding Site from the c-jun Promoter J. Biol. Chem., December 15, 1995; 270(50): 30084 - 30092. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |